Cambridge Investment Research Advisors’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDV
ACA
CIA
CAI
HPC
Cambridge Investment Research Advisors's IBDV Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 3.4% in Q1 2026, buying an estimated $287K and bringing the position to 393,979 shares worth $8.62M. The position accounts for 0.02% of the portfolio, ranked #677.
Cambridge Investment Research Advisors first reported a position in IBDV in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.87M in Q1 2024. 335 funds tracked by Wall St. Rank hold IBDV as of Q1 2026.
- Cambridge Investment Research Advisors held 393,979 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $8.62M as of Q1 2026.
- Cambridge Investment Research Advisors bought 12,998 iShares iBonds Dec 2030 Term Corporate ETF shares in Q1 2026, an estimated $287K.
- iShares iBonds Dec 2030 Term Corporate ETF made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #677 holding.
- Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q4 2022 and has held it in 14 quarters since.
- Cambridge Investment Research Advisors's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $9.87M in Q1 2024.
- 335 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.